Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
Nosa Plugs AB, a medical technology firm, specializes in developing and marketing intranasal respiratory aids, predominantly across Europe and North America. Their NOSA product portfolio encompasses various solutions: odor control devices for protection against unpleasant smells; microbial control products engineered to diminish the inhalation of viruses and bacteria through the nose; and allergy filters designed to screen out detrimental airborne matter like pollen, pet dander, dust, and mold. The company, established in 2014, is based in Stockholm, Sweden.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITD.